Bookmark list

Siegfried restarts production after cyber attack

31-May-2021 - Switzerland

The Siegfried Group has largely overcome the consequences of the cyber attack that occurred shortly before Pentecost and has begun to ramp up production again. Some sites had continued or resumed operations to a certain extent last week. Other sites will follow in the next days, including the Hameln site, which is important for vaccine filling and finishing and shall start unrestricted operations at the beginning of the week. The two sites in Spain acquired at the beginning of the year were not affected by the attack and were productive without interruption.

Symbolic image

pixabay.com

As a result of the attack, there will be certain volume and revenue shortfalls in the first half of the year with cost continuing to run during the short interruption, but these are expected to be made up for the full year. Based on the results of the forensic investigations, which are well advanced, the Siegfried Group continues to assume that no sensitive customer data were affected by the incident.

The cleanup of this particular situation will take a few more days. After the initial focus of the work was on the production-related systems, all remaining systems will also be restored in the next and final phase. Permanent damage to the IT infrastructure, IT systems or equipment is not expected.

https://www.bionity.com/en/news/1171280/siegfried-restarts-production-after-cyber-attack.html

Siegfried affected by attack on its IT systems

Production interruption with the exception of the two sites in Spain

Get the life science industry in your inbox

Siegfried restarts production after cyber attack

Siegfried affected by attack on its IT systems

Other news from the department manufacturing

BASF to build new fermentation plant for crop protection products in Ludwigshafen

SCHOTT Pharma to expand in the U.S.

World’s First Pilot Plant for Bio-Based Aniline

Biotech startup Enifer secures €12 million grant to build a first-of-its-kind mycoprotein ingredient factory

Lilly to expand injectable manufacturing capacity with planned $2.5 billion site in Germany

Gerresheimer: Groundbreaking ceremony for plant expansion in Querétaro, Mexico

Automated, cost-effective production of mRNA vaccines as well as cell and gene therapeutics

Vetter looks ahead to further expansions to meet supply chain demand

Bayer invests 250 million Euros in new production facility in Finland

Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval

Sartorius opens manufacturing facility for cell culture media in Puerto Rico

Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA

Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides

Merck Invests Approximately € 70 Million to Expand Reagent Manufacturing in China

Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing

Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies

GEA invests EUR 50 million in German centrifuge production sites

Drug shortages: These factors lead to supply bottlenecks in the pharmaceutical industry

Lonza Completes Expansion of Conjugation Facility in Visp

Eppendorf: New production site in Shanghai metropolitan region

Get the life science industry in your inbox

Most read news

Common household chemicals pose new threat to brain health

Sustainable plastics from agricultural waste

The mother's protein intake affects the newborn's face

Unfavourable carbohydrates early in the morning - a potential problem for "owls"

Microbe of the Year 2023: Bacillus subtilis – for health and technology

Memory self-test via smartphone can identify early signs of Alzheimer’s disease

Innovative treatment helmet from a Basel spin-off promises advances in the treatment of Alzheimer’s

Hypoallergenic pets: dream or reality?

Gut microbiota and antibiotics: Missing puzzle piece discovered

Possible billion-euro deal: Novo Nordisk wants to acquire MHH spin-off

Presence of nicotine and antidepressants detected in Antarctic waters

Music and Genomes: Beethoven’s Genes Put to the Test

More news from our other portals

Battery material for the sodium-ion revolution

Sweet success: researchers crack sugarcane’s complex genetic code

Nosy chemistry

Nadja Håkansson appointed Chief Executive Officer of thyssenkrupp Uhde

Milk on ice: Antarctic time capsule of whole milk powder sheds light on the enduring qualities—and evolution—of dairy products past and present

Novel UV Broadband Spectrometer Revolutionises Air Pollutant Analysis

More efficient, lighter, more sustainable: researchers develop next-generation batteries

An avocado a day may improve overall diet quality

Advanced imaging techniques on a semiconductor material reveal ‘surprising’ hidden activity

Tests confirm quality of purified graphite from used lithium-ion batteries

Asparagus enjoyment - that's what counts

Fraunhofer IPMS develops new multi-sensor system for water analysis

Highest power efficiency achieved in flexible solar cells using new fabrication technique

Green light from the antitrust authorities

Particle surface properties and their understanding - a trend also among young scientists

Atomic-scale semiconductor process technology and clean hydrogen technology join hands

Smart formulation in food technology

Research team develops sodium battery capable of rapid charging in just a few seconds

Brand DNA in a green bottle: Veltins Helles Lager creates full refreshment enjoyment

New reactor could save millions when making ingredients for plastics and rubber from natural gas

Gustavo Gusto calls the "Ghostbusters"

New materials discovered for safe, high-performance solid-state lithium-ion batteries

AI campaign for healthy soils

Creation of digital twins of machines in minutes

Equal rights for vegetables!

Fighting cancer: latest developments and advances